• Profile
Close

Combined use of ICG and technetium does not improve sentinel lymph node detection in endometrial cancer: Results of the COMBITEC study

Gynecologic Oncology May 18, 2021

Cabrera S, Barahona-Orpinell M, Almansa-González C, et al. - Since scarce evidence exists regarding the advantage of integrating technetium ( 99m Tc) and indocyanine green (ICG) for sentinel lymph node (SLN) biopsy in endometrial cancer, researchers herein compared the overall as well as bilateral pelvic identification rates of SLNs in two retrospective cohorts: ICG exclusive vs combined ICG+ 99m Tc. This analysis involved 180 patients, 51% (n = 92) in ICG group and 49% (n = 88) in ICG+ 99m Tc group. The overall detection rate was estimated to be 92.8% without significant variations between groups. In terms of bilateral pelvic and aortic mapping rate, no significant differences were noted. Findings showed that no improvement in SLN detection in endometrial cancer was obtained after combining preoperative 99m Tc to intraoperative ICG, but longer procedures resulted from implementing this strategy.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay